• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The Promise of Intranasal Esketamine as a Novel and Effective Antidepressant.

作者信息

Quintana Daniel S, Steen Nils Eiel, Andreassen Ole A

机构信息

NORMENT-KG Jebsen Centre for Psychosis Research, Division of Mental Health and Addiction, Oslo University Hospital & Institute of Clinical Medicine, University of Oslo, Oslo, Norway.

出版信息

JAMA Psychiatry. 2018 Feb 1;75(2):123-124. doi: 10.1001/jamapsychiatry.2017.3738.

DOI:10.1001/jamapsychiatry.2017.3738
PMID:29282452
Abstract
摘要

相似文献

1
The Promise of Intranasal Esketamine as a Novel and Effective Antidepressant.鼻内艾司氯胺酮作为一种新型有效抗抑郁药的前景。
JAMA Psychiatry. 2018 Feb 1;75(2):123-124. doi: 10.1001/jamapsychiatry.2017.3738.
2
Intranasal esketamine: A novel drug for treatment-resistant depression.鼻内依他佐辛：一种用于治疗抵抗性抑郁症的新型药物。
Am J Health Syst Pharm. 2020 Aug 20;77(17):1382-1388. doi: 10.1093/ajhp/zxaa191.
3
Efficacy and safety of intranasal esketamine for the treatment of major depressive disorder.鼻腔内给予 Esketamine 治疗重性抑郁障碍的疗效和安全性。
Expert Opin Pharmacother. 2020 Jan;21(1):9-20. doi: 10.1080/14656566.2019.1683161. Epub 2019 Oct 30.
4
Adjunctive Intranasal Esketamine in Treatment-Resistant Depression.辅助性鼻内艾司氯胺酮治疗难治性抑郁症
JAMA Psychiatry. 2018 Jun 1;75(6):654. doi: 10.1001/jamapsychiatry.2018.0690.
5
Adjunctive Intranasal Esketamine in Treatment-Resistant Depression-Reply.辅助性鼻内艾司氯胺酮治疗难治性抑郁症的回复
JAMA Psychiatry. 2018 Jun 1;75(6):654-655. doi: 10.1001/jamapsychiatry.2018.0430.
6
Antidepressant effect of prolonged twice-weekly intranasal esketamine treatments after nonresponse to electroconvulsive therapy in a patient with treatment-resistant depression.一名难治性抑郁症患者在对电休克治疗无反应后，每周两次延长鼻内给予艾氯胺酮治疗的抗抑郁作用。
Ann Clin Psychiatry. 2022 Feb;34(1):61-64. doi: 10.12788/acp.0055.
7
Comment on a Word to the Wise About Intranasal Esketamine.关于鼻内用艾司氯胺酮的明智之言的评论
Am J Psychiatry. 2019 Oct 1;176(10):856-857. doi: 10.1176/appi.ajp.2019.19070688.
8
Long-term treatment of depression with intranasal esketamine: Is it justified?
Asian J Psychiatr. 2020 Dec;54:102232. doi: 10.1016/j.ajp.2020.102232. Epub 2020 Jun 16.
9
The effects of intranasal esketamine (84 mg) and oral mirtazapine (30 mg) on on-road driving performance: a double-blind, placebo-controlled study.鼻腔内给予艾司氯胺酮（84 毫克）和口服米氮平（30 毫克）对道路驾驶表现的影响：一项双盲、安慰剂对照研究。
Psychopharmacology (Berl). 2017 Nov;234(21):3175-3183. doi: 10.1007/s00213-017-4706-6. Epub 2017 Jul 28.
10
Esketamine nasal spray (Spravato) for treatment-resistant depression.艾氯胺酮鼻喷雾剂（斯帕托）用于治疗抵抗性抑郁症。
Med Lett Drugs Ther. 2019 Apr 8;61(1569):54-57.

引用本文的文献

1
Enhanced antidepressant effects of BDNF-quercetin alginate nanogels for depression therapy.BDNF-槲皮素海藻酸钠纳米凝胶增强抗抑郁作用，用于抑郁症治疗。
J Nanobiotechnology. 2023 Oct 18;21(1):379. doi: 10.1186/s12951-023-02150-4.
2
Cost-Utility Analysis of Esketamine for Patients with Treatment-Resistant Depression in Italy.意大利使用依他佐辛治疗难治性抑郁症的成本-效用分析。
Pharmacoeconomics. 2023 Feb;41(2):209-225. doi: 10.1007/s40273-022-01220-z. Epub 2023 Jan 20.
3
miR-218 in Adolescence Predicts and Mediates Vulnerability to Stress.
miR-218 在青春期预测和介导对压力的易感性。
Biol Psychiatry. 2021 May 1;89(9):911-919. doi: 10.1016/j.biopsych.2020.10.015. Epub 2020 Nov 2.
4
Assessing the feasibility of intranasal radiotracer administration for in brain PET imaging.评估经鼻给予放射性示踪剂用于脑 PET 成像的可行性。
Nucl Med Biol. 2018 Nov;66:32-39. doi: 10.1016/j.nucmedbio.2018.08.005. Epub 2018 Aug 30.